New Discoveries in the Field of Brain Cancer in Dublin
Three New Subtypes of Brain Cancer Were Identified at RCSI University of Medicine and Health Sciences in Dublin. They are all a type of glioblastoma.
This discovery is vital, as these subtypes can help to identify new, effective therapies. Currently, the cause of most glioblastomas is unknown. Genetic disorders, such as neurofibromatosis and Li–Fraumeni syndrome, as well as previous radiation therapy, are potential risk factors.
Studies have shown that glioblastoma can be placed into three categories based on the different kinds of non-cancerous cells found within the tumor.
At the present time, most patients with glioblastoma receive the same treatment. The discovery, however, will make it possible to apply for precision medicine. That means that patients will receive treatment specific to the cells in their tumors.
Precision medicine could include the use of immune-targeting therapies in patients with a tumor subtype defined by high levels of immune cells within the microenvironment of their tumor. Moreover, the data has already shown that this approach has improved outcomes compared to others.
